Analyze Diet
Equine veterinary journal2014; 47(6); 667-674; doi: 10.1111/evj.12350

Characterisation of immune responses in healthy foals when a multivalent vaccine protocol was initiated at age 90 or 180 days.

Abstract: Protection from infectious disease requires antigen-specific immunity. In foals, most vaccine protocols are delayed until 6 months to avoid maternal antibody interference. Susceptibility to disease may exist prior to administration of vaccination at age 4-6 months. Objective: The aim of this investigation was to characterise immune activation among healthy foals in response to a multivalent vaccine protocol and compare immune responses when foals were vaccinated at age either 90 or 180 days. Methods: Randomised block design. Methods: Twelve healthy foals with colostral transfer were blocked for age and randomly assigned to vaccination at age 90 days (treatment) or at age 180 days (control). Vaccination protocols included a 3-dose series and booster vaccine administered at age 11 months. Results: Immune response following vaccination at age 90 or 180 days was comparable for several measures of cellular immunity. Antigen specific CD4+ and CD8+ expression of interleukin-4, interferon-γ and granzyme B to eastern equine encephalomyelitis, western equine encephalomyelitis, West Nile virus, tetanus toxoid, equine influenza and equine herpesvirus-1/4 antigens were evident for both groups 30 days after initial vaccine and at age 344 days. Both groups showed a significant increase in antigen-specific immunoglobulin G expression following booster vaccine at age 11 months, thereby indicating memory immune responses. Conclusions: The data presented in this report demonstrate that young foals are capable of immune activation following a 3-dose series with a multivalent vaccine, despite presence of maternal antibodies. Although immune activation does not automatically confer protection, several of the immune indicators measured showed comparable expression in foals vaccinated at 3 months relative to control foals vaccinated at age 6 months. In high-risk situations where immunity may be required earlier than following a conventional vaccine series, our data provide evidence that foals respond to immunisation initiated at 3 months in a comparable manner to foals initiated at an older age.
Publication Date: 2014-12-30 PubMed ID: 25205445DOI: 10.1111/evj.12350Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research focuses on comparing the immune response of foals after receiving a multivalent vaccine either at 90 days or 180 days of age. The results show that foals as young as 90 days can effectively activate their immune system with this vaccine, despite the presence of maternal antibodies, which could suggest earlier vaccination may be viable in higher-risk situations.

Research Objective

The main aim of the study was to understand how a foal’s immune system responds to a multivalent vaccine protocol when administered at either 90 days or 180 days of age. It was desired to know if earlier administration of the vaccine could still bring about effective immunity, given that most vaccination protocols are usually delayed till 6 months to prevent interference by maternal antibodies.

  • In the realm of equine health, most vaccination protocols are initiated when the foal reaches six months of age.
  • This is to avoid interference caused by maternal antibodies.
  • However, this delay could leave foals susceptible to diseases before vaccination commences.

Methodology

The researchers used a randomised block design for the experiment in which 12 healthy foals, who had received colostral transfer, were used. These foals were divided into two groups, one of which received the multivalent vaccine at 90 days (the treatment group), the other at 180 days (the control group).

  • Colostral transfer refers to the transfer of a mother’s first milk, called colostrum, which is rich in antibodies and nutrients.
  • The multivalent vaccine protocol consisted of a three-dose series followed by a booster vaccine at 11 months.

Results

The immune responses observed in both groups were largely comparable. Measures of cellular immunity – specific expressions of CD4+,CD8+, interleukin-4, interferon-γ, and granzyme B – were similar in response to multiple disease antigens. Both groups also demonstrated significant increase in antigen-specific immunoglobulin G expression after receiving the booster at 11 months.

  • CD4+, CD8+, interleukin-4, interferon-γ, and granzyme B are all indicators of immune system activity.
  • The antigens used in the research were from a variety of diseases including eastern equine encephalomyelitis, western equine encephalomyelitis, West Nile virus, tetanus toxoid, equine influenza and equine herpesvirus-1/4.
  • The increase in immunoglobulin G expression signifies the activation of ‘memory’ immune responses.

Conclusions

The results showed that young foals, even those as young as three months, are capable of activating their immune responses effectively when given a series of three injections of a multivalent vaccine, regardless of the presence of maternal antibodies. The study therefore suggests that early vaccination might be a plausible option in situations where foals are at high risk and hence, require immunity earlier than conventional protocols allow.

  • This discovery could have significant implications for high-risk situations where early onset of immunity in foals might be vital.
  • However, the researchers caution that immune activation does not necessarily equal protection against diseases and further research would be needed to explore the protective effects of the vaccine protocol used.

Cite This Article

APA
Davis EG, Bello NM, Bryan AJ, Hankins K, Wilkerson M. (2014). Characterisation of immune responses in healthy foals when a multivalent vaccine protocol was initiated at age 90 or 180 days. Equine Vet J, 47(6), 667-674. https://doi.org/10.1111/evj.12350

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 47
Issue: 6
Pages: 667-674

Researcher Affiliations

Davis, E G
  • Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, USA.
Bello, N M
  • Department of Statistics, Kansas State University, Manhattan, USA.
Bryan, A J
  • Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, USA.
Hankins, K
  • Zoetis Animal Health, Florham Park, New Jersey, USA.
Wilkerson, M
  • Diagnostic Medicine Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, USA.

MeSH Terms

  • Aging
  • Animals
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology
  • Antigens, Viral / immunology
  • CD4-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / metabolism
  • Gene Expression Regulation / immunology
  • Genes, MHC Class II / immunology
  • Granzymes / genetics
  • Granzymes / metabolism
  • Horse Diseases / prevention & control
  • Horses
  • Immunization Schedule
  • Interferon-gamma / genetics
  • Interferon-gamma / metabolism
  • Interleukin-4 / genetics
  • Interleukin-4 / metabolism
  • Viral Vaccines / administration & dosage
  • Viral Vaccines / immunology
  • Virus Diseases / prevention & control
  • Virus Diseases / veterinary

Citations

This article has been cited 3 times.
  1. Desanti-Consoli H, Bouillon J, Chapuis RJJ. Equids' Core Vaccines Guidelines in North America: Considerations and Prospective.. Vaccines (Basel) 2022 Mar 4;10(3).
    doi: 10.3390/vaccines10030398pubmed: 35335029google scholar: lookup
  2. Çokçalışkan C, Türkoğlu T, Uzunlu E, Sareyyüpoğlu B, Hancı İ, İpek A, Arslan A, Babak A, İldeniz G, Gülyaz V. Influence of vaccine potency and booster administration of foot-and-mouth disease vaccines on the antibody response in calves with maternal antibodies.. J Vet Sci 2017 Aug 31;18(S1):315-322.
    doi: 10.4142/jvs.2017.18.S1.315pubmed: 28859271google scholar: lookup
  3. Tallmadge RL, Miller SC, Parry SA, Felippe MJB. Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate.. PLoS One 2017;12(5):e0177831.
    doi: 10.1371/journal.pone.0177831pubmed: 28520789google scholar: lookup